SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950135-96-002629
Filing Date
1996-06-14
Accepted
1996-06-14 00:00:00
Documents
7
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION S-3 371304
2 MERGER AGREEMENT EX-2.1 86300
3 OPINION OF PALMER & DODGE EX-5.1 2074
4 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EX-12.1 4041
5 CONSENT OF COOPERS & LYBRAND LLP EX-23.1 1279
6 CONSENT OF ARTHUR ANDERSEN LLP EX-23.2 639
7 STATEMENT OF ELIGIBILITY & QUALIFICATION EX-25.1 17512
  Complete submission text file 0000950135-96-002629.txt   485176
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-05979 | Film No.: 96580852
SIC: 2834 Pharmaceutical Preparations